Journal of Autism and Developmental Disorders

, Volume 39, Issue 7, pp 996–1005 | Cite as

Complementary Alternative Medicine for Children with Autism: A Physician Survey

Original Paper

Abstract

Previous studies suggest over half of children with autism are using complementary alternative medicine (CAM). In this study, physicians responded (n = 539, 19% response rate) to a survey regarding CAM use in children with autism. Physicians encouraged multi-vitamins (49%), essential fatty acids (25%), melatonin (25%) and probiotics (19%) and discouraged withholding immunizations (76%), chelation (61%), anti-infectives (57%), delaying immunizations (55%) and secretin (43%). Physicians encouraging CAM were more likely to desire CAM training, inquire about CAM use, be female, be younger, and report greater autism visits, autism education and CAM knowledge. Physicians were more likely to desire CAM training, inquire about CAM and view CAM as a challenge for children with autism compared to children with other neurodevelopmental and chronic/complex conditions.

Keywords

Autism Complementary alternative medicine 

References

  1. American Academy of Pediatrics, Committee on Children with Disabilities. (2001). American Academy of Pediatrics: Counseling families who choose complementary and alternative medicine for their child with chronic illness or disability. Pediatrics, 107(3), 598–601.Google Scholar
  2. American Academy of Pediatrics, Committee on Children with Disabilities. (2005). Care coordination in the medical home: Integrating health and related systems of care for children with special health care needs. Pediatrics, 116, 1238–1244. doi:10.1542/peds.2005-2070.CrossRefGoogle Scholar
  3. Amminger, G. P., Berger, G. E., Schafer, M. R., Klier, C., Friedrich, M. H., & Feucht, M. (2007). Omega-3 fatty acids supplementation in children with autism: A double-blind randomized, placebo-controlled pilot study. Biological Psychiatry, 61(4), 551–553. doi:10.1016/j.biopsych.2006.05.007.PubMedCrossRefGoogle Scholar
  4. Andersen, I. M., Kaczmarska, J., McGrew, S. G., & Malow, B. A. (2008). Melatonin for insomnia in children with autism spectrum disorders. Journal of Child Neurology, 23(5), 482–485.PubMedCrossRefGoogle Scholar
  5. Brachlow, A. E., Ness, K. K., McPheeters, M. L., & Gurney, J. G. (2007). Comparison of indicators for a primary care medical home between children with autism or asthma and other special health care needs: National Survey of Children’s Health. Archives of Pediatrics & Adolescent Medicine, 161(4), 399–405. doi:10.1001/archpedi.161.4.399.CrossRefGoogle Scholar
  6. Brown, M. J., Willis, T., Omalu, B., & Leiker, R. (2006). Deaths resulting from hypocalcemia after administration of edetate disodium: 2003–2005. Pediatrics, 118(2), e534–e536. doi:10.1542/peds.2006-0858.PubMedCrossRefGoogle Scholar
  7. Cohen, M. H., & Eisenberg, D. M. (2002). Potential physician malpractice liability associated with complementary and integrative medical therapies. Annals of Internal Medicine, 136(8), 596–603.PubMedGoogle Scholar
  8. Cornish, E. (2002). Gluten and casein free diets in autism: a study of the effects on food choice and nutrition. Journal of Human Nutrition and Dietetics, 15(4), 261–269. doi:10.1046/j.1365-277X.2002.00372.x.PubMedCrossRefGoogle Scholar
  9. Crane, L. A., Daley, M. F., Barrow, J., Babbel, C., Beaty, B. L., Steiner, J. F., et al. (2008). Sentinel physician networks as a technique for rapid immunization policy surveys. Evaluation & the Health Professions, 31(1), 43–64. doi:10.1177/0163278707311872.CrossRefGoogle Scholar
  10. Cuzzolin, L., Zaffani, S., Murgia, V., Gangemi, M., Meneghelli, G., Chiamenti, G., et al. (2003). Patterns and perceptions of complementary/alternative medicine among paediatricians and patients’ mothers: A review of the literature. European Journal of Pediatrics, 162(12), 820–827. doi:10.1007/s00431-003-1313-9.PubMedCrossRefGoogle Scholar
  11. Dolske, M. C., Spollen, J., McKay, S., Lancashire, E., & Tolbert, L. (1993). A preliminary trial of ascorbic acid as supplemental therapy for autism. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 17(5), 765–774. doi:10.1016/0278-5846(93)90058-Z.CrossRefGoogle Scholar
  12. Dosreis, S., Weiner, C. L., Johnson, L., & Newschaffer, C. J. (2006). Autism spectrum disorder screening and management practices among general pediatric providers. Journal of Developmental and Behavioral Pediatrics, 27(2, Suppl), S88–S94. doi:10.1097/00004703-200604002-00006.PubMedCrossRefGoogle Scholar
  13. Easthope, G., Tranter, B., & Gill, G. (2000). General practitioners’ attitudes toward complementary therapies. Social Science & Medicine, 51(10), 1555–1561. doi:10.1016/S0277-9536(00)00048-4.CrossRefGoogle Scholar
  14. Elder, J. H., Shankar, M., Shuster, J., Theriaque, D., Burns, S., & Sherrill, L. (2006). The gluten-free, casein-free diet in autism: Results of a preliminary double blind clinical trial. Journal of Autism and Developmental Disorders, 36(3), 413–420. doi:10.1007/s10803-006-0079-0.PubMedCrossRefGoogle Scholar
  15. Findling, R. L., Maxwell, K., Scotese-Wojtila, L., Huang, J., Yamashita, T., & Wiznitzer, M. (1997). High-dose pyridoxine and magnesium administration in children with autistic disorder: An absence of salutary effects in a double-blind, placebo-controlled study. Journal of Autism and Developmental Disorders, 27(4), 467–478. doi:10.1023/A:1025861522935.PubMedCrossRefGoogle Scholar
  16. Fountain-Polley, S., Kawai, G., Goldstein, A., & Ninan, T. (2007). Knowledge and exposure to complementary and alternative medicine in paediatric doctors: A questionnaire survey. BMC Complementary and Alternative Medicine, 7, 38. doi:10.1186/1472-6882-7-38.PubMedCrossRefGoogle Scholar
  17. Garstang, J., & Wallis, M. (2006). Randomized controlled trial of melatonin for children with autistic spectrum disorders and sleep problems. Child: Care, Health and Development, 32(5), 585–589. doi:10.1111/j.1365-2214.2006.00616.x.CrossRefGoogle Scholar
  18. Giannotti, F., Cortesi, F., Cerquiglini, A., & Bernabei, P. (2006). An open-label study of controlled-release melatonin in treatment of sleep disorders in children with autism. Journal of Autism and Developmental Disorders, 36(6), 741–752. doi:10.1007/s10803-006-0116-z.PubMedCrossRefGoogle Scholar
  19. Goldman, E. (2008). Practical strategies for implementing integrative medicine in a primary care setting. The Journal of Medical Practice Management, 24(2), 97–101.PubMedGoogle Scholar
  20. Graham-Pole, J. (2001). “Physician, heal thyself”: How teaching holistic medicine differs from teaching CAM. Academic Medicine, 76(6), 662–664.PubMedCrossRefGoogle Scholar
  21. Grant, E., Macnab, A., & Wambera, K. (2007). The effectiveness of pediatric residency education in preparing graduates to manage neurological and neurobehavioral issues in practice. Academic Medicine, 82(3), 304–309. doi:10.1097/ACM.0b013e31803080c8.PubMedCrossRefGoogle Scholar
  22. Green, V. A., Pituch, K. A., Itchon, J., Choi, A., O’Reilly, M., & Sigafoos, J. (2006). Internet survey of treatments used by parents of children with autism. Research in Developmental Disabilities, 27(1), 70–84. doi:10.1016/j.ridd.2004.12.002.PubMedCrossRefGoogle Scholar
  23. Hanson, E., Kalish, L. A., Bunce, E., Curtis, C., McDaniel, S., Ware, J., et al. (2007). Use of complementary and alternative medicine among children diagnosed with autism spectrum disorder. Journal of Autism and Developmental Disorders, 37(4), 628–636. doi:10.1007/s10803-006-0192-0.PubMedCrossRefGoogle Scholar
  24. Harrington, J. W., Rosen, L., Garnecho, A., & Patrick, P. A. (2006). Parental perceptions and use of complementary and alternative medicine practices for children with autistic spectrum disorders in private practice. Journal of Developmental and Behavioral Pediatrics, 27(2, Suppl), S156–S161. doi:10.1097/00004703-200604002-00014.PubMedCrossRefGoogle Scholar
  25. Institute of Medicine. I. S. R. C. (2004). “Immunization safety review: Vaccines and autism”. Washington, DC: National Academies Press.Google Scholar
  26. James, S. J., Cutler, P., Melnyk, S., Jernigan, S., Janak, L., Gaylor, D. W., et al. (2004). Metabolic biomarkers of increased oxidative stress and impaired methylation capacity in children with autism. The American Journal of Clinical Nutrition, 80(6), 1611–1617.PubMedGoogle Scholar
  27. Kemper, K. J., & O’Connor, K. G. (2004). Pediatricians’ recommendations for complementary and alternative medical (CAM) therapies. Ambulatory Pediatrics, 4(6), 482–487. doi:10.1367/A04-050R.1.PubMedCrossRefGoogle Scholar
  28. Kemper, K. J., Vohra, S., & Walls, R. (2008). American Academy of Pediatrics. The use of complementary and alternative medicine in pediatrics. Pediatrics, 122(6), 1374–1386. doi:10.1542/peds.2008-2173.PubMedCrossRefGoogle Scholar
  29. Kern, J. K., & Jones, A. M. (2006). Evidence of toxicity, oxidative stress, and neuronal insult in autism. Journal of Toxicology and Environmental Health. Part B, Critical Reviews, 9(6), 485–499. doi:10.1080/10937400600882079.PubMedCrossRefGoogle Scholar
  30. Knivsberg, A. M., Reichelt, K. L., Hoien, T., & Nodland, M. (2002). A randomised, controlled study of dietary intervention in autistic syndromes. Nutritional Neuroscience, 5(4), 251–261. doi:10.1080/10284150290028945.PubMedCrossRefGoogle Scholar
  31. Kogan, M. D., Strickland, B. B., Blumberg, S. J., Singh, G. K., Perrin, J. M., & van Dyck, P. C. (2008). A national profile of the health care experiences and family impact of autism spectrum disorder among children in the United States, 2005–2006. Pediatrics, 122(6), e1149–e1158. doi:10.1542/peds.2008-1057.PubMedCrossRefGoogle Scholar
  32. Koshnick, R. L., Lilly, K. K., St Clair, K., Finnegan, M. T., & Warshaw, E. M. (2007). Use of diagnostic tests by dermatologists, podiatrists and family practitioners in the United States: Pilot data from a cross-sectional survey. Mycoses, 50(6), 463–469. doi:10.1111/j.1439-0507.2007.01422.x.PubMedCrossRefGoogle Scholar
  33. Kuriyama, S., Kamiyama, M., Watanabe, M., Tamahashi, S., Muraguchi, I., Watanabe, T., et al. (2002). Pyridoxine treatment in a subgroup of children with pervasive developmental disorders. Developmental Medicine and Child Neurology, 44(4), 284–286. doi:10.1017/S0012162201232071.PubMedCrossRefGoogle Scholar
  34. Kurtz, M. E., Nolan, R. B., & Rittinger, W. J. (2003). Primary care physicians’ attitudes and practices regarding complementary and alternative medicine. The Journal of the American Osteopathic Association, 103(12), 597–602.PubMedGoogle Scholar
  35. Levy, S. E., & Hyman, S. L. (2008). Complementary and alternative medicine treatments for children with autism spectrum disorders. Child and Adolescent Psychiatric Clinics of North America, 17(4), 803–820. doi:10.1016/j.chc.2008.06.004. ix.PubMedCrossRefGoogle Scholar
  36. Levy, S. E., Mandell, D. S., Merhar, S., Ittenbach, R. F., & Pinto-Martin, J. A. (2003). Use of complementary and alternative medicine among children recently diagnosed with autistic spectrum disorder. Journal of Developmental and Behavioral Pediatrics, 24(6), 418–423. doi:10.1097/00004703-200312000-00003.PubMedCrossRefGoogle Scholar
  37. Liptak, G. S., Orlando, M., Yingling, J. T., Theurer-Kaufman, K. L., Malay, D. P., Tompkins, L. A., et al. (2006). Satisfaction with primary health care received by families of children with developmental disabilities. Journal of Pediatric Health Care, 20(4), 245–252. doi:10.1016/j.pedhc.2005.12.008.PubMedCrossRefGoogle Scholar
  38. Mercer, L., Creighton, S., Holden, J. J., & Lewis, M. E. (2006). Parental perspectives on the causes of an autism spectrum disorder in their children. Journal of Genetic Counseling, 15(1), 41–50. doi:10.1007/s10897-005-9002-7.PubMedCrossRefGoogle Scholar
  39. Mousain-Bosc, M., Roche, M., Polge, A., Pradal-Prat, D., Rapin, J., & Bali, J. P. (2006). Improvement of neurobehavioral disorders in children supplemented with magnesium-vitamin B6. I. Attention deficit hyperactivity disorders. Magnesium Research, 19(1), 46–52.PubMedGoogle Scholar
  40. Myers, S. M., & Johnson, C. P. (2007). Management of children with autism spectrum disorders. Pediatrics, 120(5), 1162–1182. doi:10.1542/peds.2007-2362.PubMedCrossRefGoogle Scholar
  41. Overland, R., Overland, S., Johansen, K. N., & Mykletun, A. (2008). Verifiability of diagnostic categories and work ability in the context of disability pension award: A survey on gatekeeping among general practitioners in Norway. BMC Public Health, 8(1), 137. doi:10.1186/1471-2458-8-137.PubMedCrossRefGoogle Scholar
  42. The Robert Graham Center: Policy Studies in Family Medicine and Primary Care. (2004). “Number of Office Visits to Family Physicians.” US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Health Statistics, 2006 National Ambulatory Medical Care Survey.Google Scholar
  43. Sandler, R. H., Finegold, S. M., Bolte, E. R., Buchanan, C. P., Maxwell, A. P., Vaisanen, M. L., et al. (2000). Short-term benefit from oral vancomycin treatment of regressive-onset autism. Journal of Child Neurology, 15(7), 429–435. doi:10.1177/088307380001500701.PubMedCrossRefGoogle Scholar
  44. Sawni, A., & Thomas, R. (2007). Pediatricians’ attitudes, experience and referral patterns regarding complementary/alternative medicine: A national survey. BMC Complementary and Alternative Medicine, 7, 18. doi:10.1186/1472-6882-7-18.PubMedCrossRefGoogle Scholar
  45. Silverman, C., & Brosco, J. P. (2007). Understanding autism: Parents and pediatricians in historical perspective. Archives of Pediatrics & Adolescent Medicine, 161(4), 392–398. doi:10.1001/archpedi.161.4.392.CrossRefGoogle Scholar
  46. Sliwinski, S., Croonenberghs, J., Christophe, A., Deboutte, D., & Maes, M. (2006). Polyunsaturated fatty acids: Do they have a role in the pathophysiology of autism? Neuroendocrinology Letters, 27(4), 465–471.PubMedGoogle Scholar
  47. Sneed, R. C., May, W. L., & Stencel, C. S. (2000). Training of pediatricians in care of physical disabilities in children with special health needs: Results of a two-state survey of practicing pediatricians and national resident training programs. Pediatrics, 105(3 Pt 1), 554–561. doi:10.1542/peds.105.3.554.PubMedCrossRefGoogle Scholar
  48. Sturmey, P. (2005). Secretin is an ineffective treatment for pervasive developmental disabilities: A review of 15 double-blind randomized controlled trials. Research in Developmental Disabilities, 26(1), 87–97.PubMedCrossRefGoogle Scholar
  49. Vancassel, S., Durand, G., Barthelemy, C., Lejeune, B., Martineau, J., Guilloteau, D., et al. (2001). Plasma fatty acid levels in autistic children. Prostaglandins, Leukotrienes, and Essential Fatty Acids, 65(1), 1–7. doi:10.1054/plef.2001.0281.PubMedCrossRefGoogle Scholar
  50. VanGeest, J. B., Johnson, T. P., & Welch, V. L. (2007). Methodologies for improving response rates in surveys of physicians: A systematic review. Evaluation & the Health Professions, 30(4), 303–321. doi:10.1177/0163278707307899.CrossRefGoogle Scholar
  51. Weber, W., & Newmark, S. (2007). Complementary and alternative medical therapies for attention-deficit/hyperactivity disorder and autism. Pediatric Clinics of North America, 54(6), 983–1006. doi:10.1016/j.pcl.2007.09.006. xii.PubMedCrossRefGoogle Scholar
  52. Williams, K. W., Wray, J. J., & Wheeler, D. M. (2005). Intravenous secretin for autism spectrum disorder. Cochrane Database of Systematic Reviews (Online : Update Software), (3), CD003495.Google Scholar
  53. Wilson, B. G., Cruz, N. V., Fiocchi, A., & Bahna, S. L. (2008). Survey of physicians’ approach to food allergy, Part 2: Allergens, diagnosis, treatment, and prevention. Annals of Allergy, Asthma & Immunology, 100(3), 250–255.CrossRefGoogle Scholar
  54. Wong, H. H., & Smith, R. G. (2006). Patterns of complementary and alternative medical therapy use in children diagnosed with autism spectrum disorders. Journal of Autism and Developmental Disorders, 36(7), 901–909. doi:10.1007/s10803-006-0131-0.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2009

Authors and Affiliations

  1. 1.Division of General Pediatrics, Department of PediatricsUniversity of MinnesotaMinneapolisUSA

Personalised recommendations